Search

Your search keyword '"Uluer, Ahmet"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Uluer, Ahmet" Remove constraint Author: "Uluer, Ahmet" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
30 results on '"Uluer, Ahmet"'

Search Results

1. Preoperative Clearance

3. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

11. Carlos Escude’nin Çevresel (Periferik) Realizm Yaklaşımı: “Diğer Devletler”in Dış Politika Davranışına Dair.

12. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF

13. De novomutations mediate phenotypic switching in an opportunistic human lung pathogen

16. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis– Related Diabetes

17. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis-Related Diabetes

19. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

20. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis– Related Diabetes.

21. Sarmaşık Filminin Zayıf/Başarısız Devlet ve Rejim Güvenliği Kavramları Çerçevesinde İncelenmesi.

22. Development and Validation of a Respiratory-Responsive Vocal Biomarker–Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19

23. Development and Validation of a Respiratory-Responsive Vocal Biomarker–Based Tool for Generalizable Detection of Respiratory Impairment: Independent Case-Control Studies in Multiple Respiratory Conditions Including Asthma, Chronic Obstructive Pulmonary Disease, and COVID-19 (Preprint)

26. A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment

27. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis

28. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.

30. De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen.

Catalog

Books, media, physical & digital resources